KDR (Vascular Endothelial Growth Factor Receptor 2)
KDR
Primary receptor tyrosine kinase mediating VEGF-driven tumor angiogenesis.
الوظيفة
Targeted by sunitinib, sorafenib, and bevacizumab to inhibit tumor blood vessel formation.
KDR
Primary receptor tyrosine kinase mediating VEGF-driven tumor angiogenesis.
Targeted by sunitinib, sorafenib, and bevacizumab to inhibit tumor blood vessel formation.